{
    "code": "01008757",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01008757",
    "time": "2019-04-05 03:31:17",
    "許可證字號": "衛署藥製字第008757號",
    "註銷狀態": "已註銷",
    "註銷日期": "108\/03\/05",
    "註銷理由": "自請註銷",
    "有效日期": "107\/05\/25",
    "發證日期": "65\/01\/23",
    "許可證種類": "製　劑",
    "舊證字號": "00000000",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00100875708",
    "中文品名": "拔自平錠",
    "英文品名": "BASED TABLETS &quot;CURIE&quot;",
    "適應症": "由於甲狀腺機能亢進引起之疾患如巴西多氏病、甲狀腺腫、甲狀腺炎、甲狀腺手術前後",
    "劑型": "110錠劑",
    "包裝": "6~1000錠塑膠瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "METHIMAZOLE"
    ],
    "限制項目": "01國　產 1G不得製造",
    "申請商名稱": "6131101236  居禮化學藥品股份有限公司淡水廠",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "6131101236  居禮化學藥品股份有限公司淡水廠",
        "製造廠廠址": "新北市淡水區忠山里中洲子路三之一號",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6836800300",
            "成分名稱": "METHIMAZOLE",
            "含量描述": "5",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "圓凸形",
        "標記一": "CR,050",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "01008757a.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01008757&Seq=033&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "010087570001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01008757&Seq=001&Type=9"
        }
    ]
}